All four are prescription neuromodulators designed to temporarily reduce targeted muscle activity. The useful choice is not a universal brand ranking—it is the option, treatment area, and plan that fit your anatomy, goals, history, and clinician assessment.
The quick answer
AALC’s current treatment menu confirms Botox and Dysport. Xeomin and Daxxify are included for education, not as a promise of availability. Product units are not interchangeable, so unit counts cannot be used as a simple strength or price comparison.
Compare your options
A practical side-by-side guide
| Option | What is it best for? | What distinguishes it | Timing / treatment path |
|---|---|---|---|
| Botox Cosmetic | A personalized plan for common dynamic lines in multiple FDA-approved upper-face areas. | An established onabotulinumtoxinA option with several cosmetic indications. | Its label notes approximately 3–4 months of effect for glabellar lines; individual response varies. |
| Dysport | Adults discussing treatment of expression lines, particularly the glabellar area. | A prescription abobotulinumtoxinA option with product-specific dosing and spread characteristics assessed by the injector. | Onset and duration vary by patient, area, dose, and treatment history. |
| Xeomin | Adults comparing another FDA-approved botulinum toxin option for upper facial lines. | An incobotulinumtoxinA formulation without accessory proteins in the finished product. | The FDA label reports median onset of 2–7 days and typical effect up to 12–16 weeks. |
| Daxxify | Adults comparing options for moderate-to-severe glabellar lines. | A daxibotulinumtoxinA-lanm product formulated with a peptide excipient. | Treatment response and appropriate retreatment timing require clinician assessment. |
This guide is educational and does not replace an in-person medical assessment. Product, device, settings, dose, and availability can vary.
AALC begins with the expression pattern you want to soften and the movement you want to preserve. The team reviews facial anatomy, medical history, prior toxin response, and timing before recommending an available option.
Neuromodulators primarily address dynamic lines created by muscle movement. Lines that remain at rest, volume loss, or skin-texture concerns may call for a different or combined step-wise plan.
Frequently asked questions
Is one toxin stronger than the others?
There is no valid one-number strength comparison. Each product has its own potency assay and units, and those units are not interchangeable.
Which option lasts longest?
Labels and clinical studies report population-level timing, but individual duration varies with product, dose, area, anatomy, metabolism, and treatment history.
Can I switch brands?
A qualified clinician can review your prior product, dose, response, side effects, and timing before recommending an available alternative.
Does AALC offer all four products?
AALC’s current site confirms Botox and Dysport. Please confirm current product availability at your preferred office when booking.
Sources: AALC injectables · Botox FDA label · Xeomin FDA label · Daxxify FDA label
One trusted team
Build a plan around you
Book a consultation to review your goals, medical history, anatomy or skin characteristics, recovery preferences, and the options currently available at your preferred AALC office.
Book Consultation